[go: up one dir, main page]

HK1258843A1 - 糖脂化合物及其在治疗肿瘤中的用途 - Google Patents

糖脂化合物及其在治疗肿瘤中的用途

Info

Publication number
HK1258843A1
HK1258843A1 HK19101311.9A HK19101311A HK1258843A1 HK 1258843 A1 HK1258843 A1 HK 1258843A1 HK 19101311 A HK19101311 A HK 19101311A HK 1258843 A1 HK1258843 A1 HK 1258843A1
Authority
HK
Hong Kong
Prior art keywords
tumours
treatment
glycolipids
glycolipid compounds
compounds
Prior art date
Application number
HK19101311.9A
Other languages
English (en)
Inventor
Nicolai Vladimirovich Bovin
Alexander Borisovich Tuzikov
Elena Yurievna Korchagina
Stephen Henry
Graham Griffiths
Stephen Shaw
Original Assignee
Agalimmune Limited
Kode Biotech Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agalimmune Limited, Kode Biotech Limited filed Critical Agalimmune Limited
Publication of HK1258843A1 publication Critical patent/HK1258843A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
HK19101311.9A 2015-11-11 2015-11-11 糖脂化合物及其在治疗肿瘤中的用途 HK1258843A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2015/000766 WO2017082753A1 (en) 2015-11-11 2015-11-11 Glycolipid compounds and their uses in the treatment of tumours

Publications (1)

Publication Number Publication Date
HK1258843A1 true HK1258843A1 (zh) 2019-11-22

Family

ID=56117941

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19101311.9A HK1258843A1 (zh) 2015-11-11 2015-11-11 糖脂化合物及其在治疗肿瘤中的用途

Country Status (13)

Country Link
US (1) US20180344805A1 (zh)
EP (1) EP3374367A1 (zh)
JP (1) JP6758375B2 (zh)
KR (1) KR102517641B1 (zh)
CN (1) CN108463466B (zh)
AU (1) AU2015414272B2 (zh)
BR (1) BR112018009646B1 (zh)
CA (1) CA3004107C (zh)
HK (1) HK1258843A1 (zh)
IL (1) IL259205B (zh)
MX (1) MX392285B (zh)
RU (1) RU2719486C2 (zh)
WO (1) WO2017082753A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023202155B1 (en) * 2022-04-08 2023-10-26 Kode Biotech Limited Large scale production of n-acetyllactosamine derivatives
KR20250008358A (ko) * 2023-07-07 2025-01-14 주식회사 고바이오랩 락토바실러스 가세리 균주에서 유래한 당지질

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820628B2 (en) * 2005-02-22 2010-10-26 University Of Massachusetts Medical School Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding
AU2008311480B2 (en) * 2007-10-12 2013-03-14 Kode Biotech Limited Functional lipid constructs
MX360254B (es) 2011-03-10 2018-10-26 Pfizer Combinacion de terapias inmunomoduladoras local y sistemica para tratamiento mejorado del cancer.
SG11201703957VA (en) * 2014-11-21 2017-06-29 Nicolai Vladimirovich Bovin Multivalent ligand-lipid constructs

Also Published As

Publication number Publication date
BR112018009646B1 (pt) 2020-03-31
CA3004107A1 (en) 2017-05-18
RU2018121273A3 (zh) 2019-12-13
IL259205A (en) 2018-07-31
US20180344805A1 (en) 2018-12-06
CA3004107C (en) 2023-10-17
RU2719486C2 (ru) 2020-04-17
EP3374367A1 (en) 2018-09-19
KR20180099651A (ko) 2018-09-05
MX392285B (es) 2025-03-24
BR112018009646A2 (pt) 2018-12-11
RU2018121273A (ru) 2019-12-13
JP6758375B2 (ja) 2020-09-23
IL259205B (en) 2021-06-30
WO2017082753A1 (en) 2017-05-18
CN108463466B (zh) 2021-07-09
JP2018533616A (ja) 2018-11-15
AU2015414272B2 (en) 2021-04-22
MX2018005828A (es) 2019-02-20
CN108463466A (zh) 2018-08-28
AU2015414272A1 (en) 2018-04-26
KR102517641B1 (ko) 2023-04-05

Similar Documents

Publication Publication Date Title
IL255509B (en) Compounds as modulators of ccr2, pharmaceutical preparations containing them and their use in the treatment of diseases
TW201613901A (en) New compounds
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
SG11201802915WA (en) Cancer treatment composition combining anti-cd26 antibody and other anticancer agent
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
IL256684B (en) Medicinal compounds and preparations for the treatment of social disorders and substance use disorders
MX2020004476A (es) Compuestos piridinicos de pladienolida y metodos de uso.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
HUE055132T2 (hu) Virulenciában gyengített baktériumok rosszindulatú szolid tumorok kezelésére
MX392475B (es) Una forma en estado solido de compuestos de pladienolida piridina y metodos de uso
IL249640A0 (en) Preparations for the treatment of nosebleeds
HK1254231A1 (zh) 米托-和厚朴酚化合物及其合成方法和用途
IL248735A0 (en) Preparations containing glycolipid for use in the treatment of tumors
HK1258843A1 (zh) 糖脂化合物及其在治疗肿瘤中的用途
IL249860A0 (en) Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer
MY182818A (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
PL3548006T3 (pl) Kompozycja do stosowania w leczeniu zmian jelitowych
IL255168A0 (en) Treatment combination of an anti-pogatactic factor and an anti-cancer factor and compounds for the treatment of cancer
PT3415142T (pt) Composição para o tratamento de blefarite que contém terpinen-4-ol
MY182809A (en) Compositions for the treatment of kidney and/or liver disease
HK1237265A1 (zh) 用於治疗癌症的联合治疗组合物和联合治疗方法
HK1240079A1 (zh) 用於治疗多汗症的方法
AU2015902659A0 (en) Therapeutic compounds and compositions for treating social disorders and substance use disorders
HK1242965A1 (zh) 用於治疗结直肠癌的阿吡莫德